Literature DB >> 19457079

Abeta43 is more frequent than Abeta40 in amyloid plaque cores from Alzheimer disease brains.

Hedvig Welander1, Jenny Frånberg, Caroline Graff, Erik Sundström, Bengt Winblad, Lars O Tjernberg.   

Abstract

One hallmark of Alzheimer disease (AD) is the extracellular deposition of the amyloid beta-peptide (Abeta) in senile plaques. Two major forms of Abeta are produced, 40 (Abeta40) and 42 (Abeta42) residues long. The most abundant form of Abeta is Abeta40, while Abeta42 is more hydrophobic and more prone to form toxic oligomers and the species of particular importance in early plaque formation. Thus, the length of the hydrophobic C-terminal seems to be very important for the oligomerization and neurotoxicity of the Abeta peptide. Here we investigated which Abeta species are deposited in AD brain. We analyzed plaque cores, prepared from occipital and frontal cortex, from sporadic and familial AD cases and performed a quantitative study using Abeta standard peptides. Cyanogen bromide was used to generate C-terminal Abeta fragments, which were analyzed by HPLC coupled to an electrospray ionisation ion trap mass spectrometer. We found a longer peptide, Abeta43, to be more frequent than Abeta40. No variants longer than Abeta43 could be observed in any of the brains. Immunohistochemistry was performed and was found to be in line with our findings. Abeta1-43 polymerizes rapidly and we suggest that this variant may be of importance for AD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19457079     DOI: 10.1111/j.1471-4159.2009.06170.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  62 in total

Review 1.  Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease.

Authors:  Colin L Masters; Dennis J Selkoe
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

2.  β-Secretase-1 elevation in aged monkey and Alzheimer's disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and β-amyloid accumulation.

Authors:  Yan Cai; Kun Xiong; Xue-Mei Zhang; Huaibin Cai; Xue-Gang Luo; Jia-Chun Feng; Richard W Clough; Robert G Struble; Peter R Patrylo; Yaping Chu; Jeffrey H Kordower; Xiao-Xin Yan
Journal:  Eur J Neurosci       Date:  2010-08-18       Impact factor: 3.386

3.  Identification of novel γ-secretase-associated proteins in detergent-resistant membranes from brain.

Authors:  Ji-Yeun Hur; Yasuhiro Teranishi; Takahiro Kihara; Natsuko Goto Yamamoto; Mitsuhiro Inoue; Waltteri Hosia; Masakazu Hashimoto; Bengt Winblad; Susanne Frykman; Lars O Tjernberg
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

4.  New mouse model of Alzheimer's.

Authors:  Per Nilsson; Takashi Saito; Takaomi C Saido
Journal:  ACS Chem Neurosci       Date:  2014-05-22       Impact factor: 4.418

Review 5.  The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics.

Authors:  Eric Karran; Marc Mercken; Bart De Strooper
Journal:  Nat Rev Drug Discov       Date:  2011-08-19       Impact factor: 84.694

6.  An overlooked neurotoxic species in Alzheimer's disease.

Authors:  Iryna Benilova; Bart De Strooper
Journal:  Nat Neurosci       Date:  2011-07-26       Impact factor: 24.884

7.  The PSEN1 I143T mutation in a Swedish family with Alzheimer's disease: clinical report and quantification of Aβ in different brain regions.

Authors:  Lina Keller; Hedvig Welander; Huei-Hsin Chiang; Lars O Tjernberg; Inger Nennesmo; Asa K Wallin; Caroline Graff
Journal:  Eur J Hum Genet       Date:  2010-07-14       Impact factor: 4.246

8.  Pyroglutamate amyloid β (Aβ) aggravates behavioral deficits in transgenic amyloid mouse model for Alzheimer disease.

Authors:  Jessica L Wittnam; Erik Portelius; Henrik Zetterberg; Mikael K Gustavsson; Stephan Schilling; Birgit Koch; Hans-Ulrich Demuth; Kaj Blennow; Oliver Wirths; Thomas A Bayer
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

9.  Analysis of a compartmental model of amyloid beta production, irreversible loss and exchange in humans.

Authors:  Donald L Elbert; Bruce W Patterson; Randall J Bateman
Journal:  Math Biosci       Date:  2014-12-09       Impact factor: 2.144

10.  Amyloid-beta isoform metabolism quantitation by stable isotope-labeled kinetics.

Authors:  Kwasi G Mawuenyega; Tom Kasten; Wendy Sigurdson; Randall J Bateman
Journal:  Anal Biochem       Date:  2013-05-25       Impact factor: 3.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.